Loading analysis...
Loading Truth Social...
Loading live updates...
—
S&P 500— —
Nasdaq— —
Dow Jones— —
载入时间机器…
Recent CRL News Headlines
Latest news coverage for CRL aggregated from WSJ, Bloomberg, The New York Times, Financial Times, and Google News. Real-time updates, free and ad-free.
- Charles River Laboratories Schedules Third-Quarter 2026 Earnings Release and Conference Call
- Charles River Labs CEO Shannon Parisotto sells $302k in stock
- Charles River Laboratories (CRL) Stock Fair Value Rises After Analyst Day Target Increases
- Charles River Associates (CRA) Adds Harvard Business School Professor as Academic Affiliate to Antitrust & Competition Economics Practice
- UBS resumes Charles River Labs stock coverage with buy rating
- Demand Stabilization Fuels Charles River Laboratories International’s (CRL) Recovery
- Charles River Laboratories International, Inc. Income Statement – HAN:RV6
- Charles River Associates (CRA) Names Patrick Hillan Vice President, Expanding Life Sciences Commercial Strategy Expertise
- Jefferies raises Charles River Labs stock price target on cost efficiency outlook
- Is Charles River Laboratories Stock Outperforming the S&P 500?
- Is Charles River Laboratories Stock Outperforming the S&P 500?
- Charles River Laboratories: Positive Investor Day Is Fully Priced In (NYSE:CRL)
- Mizuho raises Charles River Labs stock price target to $295 on outlook
- TD Cowen raises Charles River Labs stock price target on growth outlook
- RBC Capital maintains Outperform rating on Charles River, $322 price target
CRL options: max pain, gamma exposure (GEX) & key levels · Search CRL in the news archive · All tickers
Settings
Appearance
Card Style
Language
Notifications
Live View Style
Trump Truth Social
About
Version
2.6.1
Data Source
r/wallstreetbets
AI Engine
ChatGPT/Gemini/Claude
MCP Server
https://mcp.sellthenews.org/mcp
Contact Us
[email protected]